Literature DB >> 6951494

Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients.

P C Dau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6951494     DOI： 10.1111/j.1749-6632.1981.tb33768.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

Review 1.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

2.  Internal medicine-important advances in clinical medicine: plasmapheresis as therapy.

Authors:  R T Reid; A M Jaffer
Journal:  West J Med       Date:  1983-05

Review 3.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Authors:  R Mantegazza; C Antozzi; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

5.  Immunoadsorption therapy for myasthenia gravis.

Authors:  N Shibuya; T Sato; M Osame; T Takegami; S Doi; S Kawanami
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

Review 6.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

7.  A short plasma exchange protocol is effective in severe myasthenia gravis.

Authors:  C Antozzi; M Gemma; B Regi; E Berta; P Confalonieri; D Peluchetti; R Mantegazza; F Baggi; M Marconi; F Fiacchino
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

8.  Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: a randomised trial.

Authors:  Isha Trikha; Sumit Singh; Vinay Goyal; Garima Shukla; Rama Bhasin; Madhuri Behari
Journal:  J Neurol       Date:  2007-08-11       Impact factor: 4.849

9.  Current and emerging treatments for the management of myasthenia gravis.

Authors:  Sivakumar Sathasivam
Journal:  Ther Clin Risk Manag       Date:  2011-07-22       Impact factor: 2.423

Review 10.  Plasma exchange for myasthenia gravis.

Authors:  P Gajdos; S Chevret; K Toyka
Journal:  Cochrane Database Syst Rev       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.